Skip to main content
Inventage Lab Inc. logo

Inventage Lab Inc. — Investor Relations & Filings

Ticker · 389470 ISIN · KR7389470006 KO Professional, scientific and technical activities
Open in API
Filings indexed 195 across all filing types
Latest filing 2024-09-20 Share Issue/Capital Cha…
Country KR South Korea
Listing KO 389470

About Inventage Lab Inc.

https://www.inventagelab.com/m/en/

Inventage Lab Inc. is a biopharmaceutical company specializing in the development of advanced Drug Delivery Systems (DDS). The company's foundation is its proprietary microfluidics-based platform technology, Laminar-FluiDigm™, which is applied to pharmaceutical research and manufacturing. Inventage Lab operates two primary platforms: IVL-DrugFluidic® for developing and producing microsphere-based long-acting injectables, and IVL-GeneFluidic® for the formulation and manufacturing of Lipid Nanoparticles (LNPs) for nucleic acid and gene therapies. The company's pipeline is focused on treating chronic and refractory diseases, with key programs targeting androgenic alopecia (male pattern baldness) and Alzheimer's disease. Other development areas include drug re-discovery for conditions like rheumatic arthritis and multiple sclerosis, and collaborative projects for HIV treatments and mRNA-based therapies.

Recent filings

Filing Released Lang Actions
증권발행결과(자율공시) (제2회차 CB)
Share Issue/Capital Change Classification · 100% confidence The document is a formal announcement regarding the 'Result of Securities Issuance' (증권 발행결과) for a private placement of convertible bonds (CB). It details the issuance amount, payment date, and the nature of the securities. This falls under the category of capital and financing updates, specifically related to the issuance of debt instruments that can be converted into equity.
2024-09-20 Korean
주요사항보고서(전환사채권발행결정)
Capital/Financing Update Classification · 100% confidence The document is a 'Major Matter Report' (주요사항보고서) filed with the Financial Supervisory Service/Korea Exchange, specifically detailing the 'Decision to Issue Convertible Bonds' (전환사채권 발행결정). It contains detailed terms of the bond issuance, including interest rates, conversion prices, put/call options, and lists of investors. This falls under the category of capital structure changes and financing activities.
2024-09-11 Korean
전환청구권행사 (제1회차)
Share Issue/Capital Change Classification · 100% confidence The document is a formal notification regarding the exercise of conversion rights (전환청구권행사) for convertible bonds (전환사채). This involves the issuance of new shares resulting from the conversion of debt into equity, which directly impacts the company's capital structure. According to the provided definitions, announcements regarding new share issues or capital changes fall under the 'SHA' category.
2024-09-10 Korean
임원ㆍ주요주주특정증권등소유상황보고서
Director's Dealing Classification · 100% confidence The document is a 'Report on Ownership of Specific Securities by Executives and Major Shareholders' (임원ㆍ주요주주 특정증권등 소유상황보고서) filed with the Korean regulatory authorities (Financial Supervisory Service/KRX). It details the change in share ownership by an executive (Ryu Choongho) of Inventage Lab due to the exercise of stock options. This type of filing is specifically categorized as 'Director's Dealing' (DIRS) in the provided schema, as it reports personal share transactions by company directors/executives.
2024-09-05 Korean
[기재정정]임원ㆍ주요주주특정증권등소유상황보고서
Director's Dealing Classification · 100% confidence The document is a 'Report of Ownership of Specific Securities by Executives and Major Shareholders' (임원ㆍ주요주주 특정증권등 소유상황보고서), which is a standard regulatory filing in South Korea (DART system) used to disclose insider shareholdings and changes therein. This falls under the category of 'Director's Dealing' (DIRS) as it details personal share transactions and ownership status by a company executive (Ryu Choongho).
2024-09-05 Korean
임원ㆍ주요주주특정증권등소유상황보고서
Director's Dealing Classification · 100% confidence The document is a 'Report on Ownership of Specific Securities by Executives and Major Shareholders' (임원ㆍ주요주주 특정증권등 소유상황보고서) filed with the Korean Financial Supervisory Service. This type of filing is used to disclose insider transactions, specifically the exercise of stock options by an executive (Kim Wanju). In the provided classification schema, reports of personal share transactions by company directors and executives are categorized as 'Director's Dealing' (DIRS).
2024-09-05 Korean

Browse filings by year

6 years

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.